Blur Relief

Blur Relief is a **homeopathic ophthalmic drug product** marketed by TRP Company as a sterile eye drop solution for temporary relief of blurry vision, dry, red, or tired eyes, glare associated with poor night vision, difficulty reading, and presbyopia. It is a **multi-ingredient micro-dilution formulation** containing Cineraria maritima 5X, Calcarea fluorica 13X, Conium maculatum 6X, Euphrasia stricta 6X, Gelsemium sempervirens root 6X, Natrum muriaticum 6X, and Ruta graveolens 6X. The product does not have a well-defined conventional pharmacologic mechanism or validated biological target; its claimed activity is based on homeopathic principles rather than established receptor-mediated or molecular pharmacology. Blur Relief has been sold as an over-the-counter eye drop product, but it is an **unapproved homeopathic drug** and was among the ophthalmic products cited by the FDA in a September 2023 warning letter to TRP Company for marketing unapproved new drugs.

Brand names

Blur Relief